republic-os/legislation/us/states/va/2026/hb-795.md

type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags

type	title	description	jurisdiction	legislature	session	identifier	citation	classification	subjects	status	primary_sponsors	version_count	action_count	vote_count	first_action	last_action	source	source_identifier	source_url	source_hash	vintage	source_snapshot	retrieved_at	confidence	tags
Bill	Health insurance; requirements for certain opioid antagonists.	Health insurance; requirements for certain opioid antagonists. Requires each health insurer, corporation providing health care subscription plans, and health maintenance organization whose policy, contract, or plan includes coverage for prescription drugs to include coverage for at least one other opioid antagonist used for overdose reversal dispensed pursuant to an oral, written, or standing order of a prescriber and ensure that cost-sharing for at least one opioid antagonist used for overdose reversal is included on the lowest cost tier of the insurer's, corporation's, or health maintenance organization's prescription drug formulary. The bill provides that such coverage shall be exempt from any prior authorization or step therapy requirement on coverage of benefits. As introduced, this bill was a recommendation of the Joint Commission on Health Care. This bill is identical to SB 257.	us/states/va	Virginia General Assembly	2026	HB 795	Virginia HB 795 (2026)	bill		enacted	Atoosa R. Reaser	6	44	12	2026-01-13	2026-04-08	openstates	ocd-bill/7977c5bc-31ee-41c0-9783-29e0ea63e355	https://lis.virginia.gov/bill-details/20261/HB795	6c17756652c80b103becc82e99f68fb79ba1457e0267427bbb65b305f7339bce	2026-07-01	https://data.openstates.org/daily/2026-07-01/public.pgdump	2026-07-06	reported	legislation bill us-va

Virginia HB 795 (2026) — Health insurance; requirements for certain opioid antagonists.

Health insurance; requirements for certain opioid antagonists. Requires each health insurer, corporation providing health care subscription plans, and health maintenance organization whose policy, contract, or plan includes coverage for prescription drugs to include coverage for at least one other opioid antagonist used for overdose reversal dispensed pursuant to an oral, written, or standing order of a prescriber and ensure that cost-sharing for at least one opioid antagonist used for overdose reversal is included on the lowest cost tier of the insurer's, corporation's, or health maintenance organization's prescription drug formulary. The bill provides that such coverage shall be exempt from any prior authorization or step therapy requirement on coverage of benefits. As introduced, this bill was a recommendation of the Joint Commission on Health Care. This bill is identical to SB 257.

Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

1. Introduced (filed) — source
2. Chaptered (committee substitute) — source
3. Commerce and Labor Substitute (committee substitute) — source
4. Labor and Commerce Substitute (committee substitute) — source
5. Subcommittee #1 Subcommittee Substitute (committee substitute) — source
6. Enrolled (enrolled) — source

Votes

• Subcommittee recommends reporting with substitute — 9–0 (pass) · lower
• H VOTE: — 96–0 (pass) · lower
• Passage R — 39–0 (pass) · upper
• Constitutional reading dispensed (on 2nd reading) — 37–0 (pass) · upper
• Reconsider R — 40–0 (pass) · upper
• Reported from Finance and Appropriations — 14–0 (pass) · upper
• H VOTE: — 96–0 (pass) · lower
• Reported from Appropriations — 22–0 (pass) · lower
• Reported from Commerce and Labor with substitute — 15–0 (pass) · upper
• Subcommittee recommends reporting — 7–0 (pass) · lower
• Passage R — 40–0 (pass) · upper
• Reported from Labor and Commerce with substitute — 22–0 (pass) · lower

Sponsors

• Atoosa R. Reaser — primary (person)

Timeline

The legislative action history — every referral, reading, and vote.

• 2026-01-13 Prefiled and ordered printed; Offered 01-14-2026 26104745D filing, introduction
• 2026-01-13 Referred to Committee on Health and Human Services referral-committee
• 2026-01-23 Fiscal Impact Statement from Department of Planning and Budget (HB795)
• 2026-01-27 Referred from Health and Human Services and referred to Labor and Commerce (Voice Vote) referral-committee
• 2026-01-28 Assigned HCL sub: Subcommittee #1 referral-committee
• 2026-02-03 House subcommittee offered
• 2026-02-03 Subcommittee recommends reporting with substitute (9-Y 0-N) substitution
• 2026-02-05 Reported from Labor and Commerce with substitute and referred to Appropriations (22-Y 0-N) committee-passage
• 2026-02-05 Committee substitute printed 26107033D-H1 substitution
• 2026-02-05 Assigned HAPP sub: Compensation and Retirement referral-committee
• 2026-02-06 Fiscal Impact Statement from Department of Planning and Budget (HB795)
• 2026-02-09 Subcommittee recommends reporting (7-Y 0-N)
• 2026-02-09 Reported from Appropriations (22-Y 0-N) committee-passage
• 2026-02-11 Read first time reading-1
• 2026-02-12 Read second time reading-2
• 2026-02-12 committee substitute agreed to substitution
• 2026-02-12 Engrossed by House - committee substitute substitution
• 2026-02-13 Read third time and passed House (96-Y 0-N 0-A) passage, reading-3
• 2026-02-16 Constitutional reading dispensed (on 1st reading)
• 2026-02-16 Referred to Committee on Commerce and Labor referral-committee
• 2026-03-09 Reported from Commerce and Labor with substitute and rereferred to Finance and Appropriations (15-Y 0-N) committee-passage
• 2026-03-09 Senate committee offered
• 2026-03-09 Committee substitute printed 26109503D-S1 substitution
• 2026-03-09 Reported from Finance and Appropriations (14-Y 0-N) committee-passage
• 2026-03-10 Fiscal Impact Statement from Department of Planning and Budget (HB795)
• 2026-03-10 Rules suspended
• 2026-03-10 Constitutional reading dispensed (on 2nd reading) (37-Y 0-N 0-A)
• 2026-03-10 Passed by for the day (Voice Vote)
• 2026-03-11 Read third time reading-3
• 2026-03-11 Commerce and Labor Substitute agreed to
• 2026-03-11 Engrossed by Senate - committee substitute substitution
• 2026-03-11 Passed Senate with substitute Block Vote (39-Y 0-N 0-A) passage
• 2026-03-11 Reconsideration of Senate passage agreed to by Senate (40-Y 0-N 0-A)
• 2026-03-11 Passed Senate with substitute Block Vote (40-Y 0-N 0-A) passage
• 2026-03-12 Senate substitute agreed to by House (96-Y 0-N 0-A) substitution
• 2026-03-30 Enrolled enrolled
• 2026-03-30 Bill text as passed House and Senate (HB795ER) passage
• 2026-03-30 Signed by President passage
• 2026-03-31 Signed by Speaker passage
• 2026-03-31 Enrolled Bill communicated to Governor on March 31, 2026 enrolled, executive-receipt
• 2026-03-31 Governor's Action Deadline 11:59 p.m., April 13, 2026 executive-receipt
• 2026-04-01 Fiscal Impact Statement from Department of Planning and Budget (HB795)
• 2026-04-08 Approved by Governor-Chapter 423 (effective 7/1/2026) executive-signature
• 2026-04-08 Acts of Assembly Chapter text (CHAP0423)

Source

OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/7977c5bc-31ee-41c0-9783-29e0ea63e355. Confidence: reported (aggregated from official Virginia legislature records).